Human Gene CSNK2A1 (ENST00000217244.9_8) from GENCODE V47lift37
|
|
Sequence and Links to Tools and Databases
|
|
Comments and Description Text from UniProtKB
|
|
ID: CSK21_HUMAN
DESCRIPTION: RecName: Full=Casein kinase II subunit alpha; Short=CK II alpha; EC=2.7.11.1;
FUNCTION: Catalytic subunit of a constitutively active serine/threonine-protein kinase complex that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Regulates numerous cellular processes, such as cell cycle progression, apoptosis and transcription, as well as viral infection. May act as a regulatory node which integrates and coordinates numerous signals leading to an appropriate cellular response. During mitosis, functions as a component of the p53/TP53-dependent spindle assembly checkpoint (SAC) that maintains cyclin-B-CDK1 activity and G2 arrest in response to spindle damage. Also required for p53/TP53-mediated apoptosis, phosphorylating 'Ser-392' of p53/TP53 following UV irradiation. Can also negatively regulate apoptosis. Phosphorylates the caspases CASP9 and CASP2 and the apoptotic regulator NOL3. Phosphorylation protects CASP9 from cleavage and activation by CASP8, and inhibits the dimerization of CASP2 and activation of CASP8. Regulates transcription by direct phosphorylation of RNA polymerases I, II, III and IV. Also phosphorylates and regulates numerous transcription factors including NF-kappa-B, STAT1, CREB1, IRF1, IRF2, ATF1, SRF, MAX, JUN, FOS, MYC and MYB. Phosphorylates Hsp90 and its co-chaperones FKBP4 and CDC37, which is essential for chaperone function. Regulates Wnt signaling by phosphorylating CTNNB1 and the transcription factor LEF1. Acts as an ectokinase that phosphorylates several extracellular proteins. During viral infection, phosphorylates various proteins involved in the viral life cycles of EBV, HSV, HBV, HCV, HIV, CMV and HPV. CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein. ENZYME REGULATION: Constitutively active protein kinase whose activity is not directly affected by phosphorylation. Seems to be regulated by level of expression and localization. SUBUNIT: Heterotetramer composed of two catalytic subunits (alpha chain and/or alpha' chain) and two regulatory subunits (beta chains). The tetramer can exist as a combination of 2 alpha/2 beta, 2 alpha'/2 beta or 1 alpha/1 alpha'/2 beta subunits. Also part of a CK2-SPT16-SSRP1 complex composed of SSRP1, SUPT16H, CSNK2A1, CSNK2A2 and CSNK2B, which forms following UV irradiation. Interacts with RNPS1. INTERACTION: O00257-3:CBX4; NbExp=2; IntAct=EBI-347804, EBI-4392727; P19784:CSNK2A2; NbExp=2; IntAct=EBI-347804, EBI-347451; P67870:CSNK2B; NbExp=10; IntAct=EBI-347804, EBI-348169; O60282:KIF5C; NbExp=4; IntAct=EBI-347804, EBI-717170; P29590:PML; NbExp=2; IntAct=EBI-347804, EBI-295890; Q96EB6:SIRT1; NbExp=2; IntAct=EBI-347804, EBI-1802965; PTM: Phosphorylated at Thr-344, Thr-360, Ser-362 and Ser-370 by CDK1 in prophase and metaphase and dephosphorylated during anaphase. Phosphorylation does not directly affect casein kinase 2 activity, but may contribute to its regulation by forming binding sites for interacting proteins and/or targeting it to different compartments. MISCELLANEOUS: Can use both ATP and GTP as phosphoryl donors. Phosphorylation by casein kinase 2 has been estimated to represent up to one quarter of the eukaryotic phosphoproteome. Casein kinase 2 has been found to be inccreased at protein level and up- regulated at the level of enzyme activity in the majority of cancers. However, elevated levels of casein kinase 2 are present in certain normal organs such as brain and testes. SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr protein kinase family. CK2 subfamily. SIMILARITY: Contains 1 protein kinase domain.
| |
|
|
Primer design for this transcript
|
|
MalaCards Disease Associations
|
|
Comparative Toxicogenomics Database (CTD)
|
|
The following chemicals interact with this gene
- D010634
Phenobarbital
- C029790
2,2',3',4,4',5-hexachlorobiphenyl
- C014211
2,3,7,8-tetrachlorodibenzofuran
- C023514
2,6-dinitrotoluene
- C492322
2-dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole
- C023035
3,4,5,3',4'-pentachlorobiphenyl
- C009505
4,4'-diaminodiphenylmethane
- C405354
4,5,6,7-tetrabromobenzotriazole
- C012606
4-vinyl-1-cyclohexene dioxide
- D000082
Acetaminophen
more ... click here to view the complete list
| |
|
|
Common Gene Haplotype Alleles
|
|
Press "+" in the title bar above to open this section.
| |
|
|
RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
|
|
Microarray Expression Data
|
|
Press "+" in the title bar above to open this section.
| |
|
|
mRNA Secondary Structure of 3' and 5' UTRs
|
|
The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.
| |
|
|
Protein Domain and Structure Information
|
|
InterPro Domains: Graphical view of domain structure IPR011009 - Kinase-like_dom
IPR000719 - Prot_kinase_cat_dom
IPR017441 - Protein_kinase_ATP_BS
IPR002290 - Ser/Thr_dual-sp_kinase_dom
IPR008271 - Ser/Thr_kinase_AS
Pfam Domains: PF00069 - Protein kinase domain
PF01636 - Phosphotransferase enzyme family
PF07714 - Protein tyrosine and serine/threonine kinase
SCOP Domains: 56112 - Protein kinase-like (PK-like)
Protein Data Bank (PDB) 3-D Structure
ModBase Predicted Comparative 3D Structure on P68400
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.
| |
|
|
Orthologous Genes in Other Species
|
|
Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
| |
|
|
Gene Ontology (GO) Annotations with Structured Vocabulary
|
|
Descriptions from all associated GenBank mRNAs
|
|
DQ354583 - Homo sapiens casein kinase 2 alpha isoform mRNA, complete cds. BC050036 - Homo sapiens casein kinase 2, alpha 1 polypeptide, mRNA (cDNA clone MGC:51015 IMAGE:5298655), complete cds. M55265 - Human casein kinase II alpha subunit mRNA, complete cds. J02853 - Homo sapiens casein kinase II alpha subunit mRNA, complete cds. S53149 - Homo sapiens casein kinase II-alpha subunit mRNA, complete cds. AK302583 - Homo sapiens cDNA FLJ57289 complete cds, highly similar to Casein kinase II subunit alpha (EC 2.7.11.1). BC002615 - Homo sapiens cDNA clone IMAGE:3140817, containing frame-shift errors. BC011668 - Homo sapiens casein kinase 2, alpha 1 polypeptide, mRNA (cDNA clone MGC:15232 IMAGE:4121882), complete cds. AK312535 - Homo sapiens cDNA, FLJ92904, highly similar to Homo sapiens casein kinase 2, alpha 1 polypeptide (CSNK2A1), mRNA. AY735339 - Homo sapiens casein kinase 2 alpha 1 subunit transcript variant 3, 5' UTR. JD427165 - Sequence 408189 from Patent EP1572962. JD135360 - Sequence 116384 from Patent EP1572962. JD044366 - Sequence 25390 from Patent EP1572962. JD348727 - Sequence 329751 from Patent EP1572962. JD085460 - Sequence 66484 from Patent EP1572962. JD119397 - Sequence 100421 from Patent EP1572962. JD119398 - Sequence 100422 from Patent EP1572962. JD380999 - Sequence 362023 from Patent EP1572962. JD034960 - Sequence 15984 from Patent EP1572962. JD117101 - Sequence 98125 from Patent EP1572962. JD043146 - Sequence 24170 from Patent EP1572962. AF323119 - Homo sapiens NF-E2-related factor 2 mRNA, partial cds. BC071167 - Homo sapiens casein kinase 2, alpha 1 polypeptide, mRNA (cDNA clone MGC:88038 IMAGE:5772615), complete cds. BC053532 - Homo sapiens casein kinase 2, alpha 1 polypeptide, mRNA (cDNA clone MGC:61540 IMAGE:3908058), complete cds. JD072520 - Sequence 53544 from Patent EP1572962. JD294996 - Sequence 276020 from Patent EP1572962. JD181980 - Sequence 163004 from Patent EP1572962. JD204118 - Sequence 185142 from Patent EP1572962. JD484094 - Sequence 465118 from Patent EP1572962. JD077153 - Sequence 58177 from Patent EP1572962. JD314210 - Sequence 295234 from Patent EP1572962. JD303025 - Sequence 284049 from Patent EP1572962. JD289986 - Sequence 271010 from Patent EP1572962. JD154000 - Sequence 135024 from Patent EP1572962. JD093205 - Sequence 74229 from Patent EP1572962. JD441988 - Sequence 423012 from Patent EP1572962. JD105028 - Sequence 86052 from Patent EP1572962. JD301995 - Sequence 283019 from Patent EP1572962. JD314652 - Sequence 295676 from Patent EP1572962. JD073095 - Sequence 54119 from Patent EP1572962. JD485410 - Sequence 466434 from Patent EP1572962. JD055631 - Sequence 36655 from Patent EP1572962. JD544284 - Sequence 525308 from Patent EP1572962. JD193647 - Sequence 174671 from Patent EP1572962. AB451279 - Homo sapiens CSNK2A1 mRNA for casein kinase II alpha 1 subunit isoform a, complete cds, clone: FLJ08116AAAN. BT019792 - Homo sapiens casein kinase 2, alpha 1 polypeptide mRNA, complete cds. DQ893102 - Synthetic construct clone IMAGE:100005732; FLH193758.01X; RZPDo839B0979D casein kinase 2, alpha 1 polypeptide (CSNK2A1) gene, encodes complete protein. KJ890987 - Synthetic construct Homo sapiens clone ccsbBroadEn_00381 CSNK2A1 gene, encodes complete protein. KJ905186 - Synthetic construct Homo sapiens clone ccsbBroadEn_14604 CSNK2A1 gene, encodes complete protein. DQ896374 - Synthetic construct Homo sapiens clone IMAGE:100010834; FLH193754.01L; RZPDo839B0969D casein kinase 2, alpha 1 polypeptide (CSNK2A1) gene, encodes complete protein. AB451411 - Homo sapiens CSNK2A1 mRNA for casein kinase II alpha 1 subunit isoform a, partial cds, clone: FLJ08116AAAF. AB590210 - Synthetic construct DNA, clone: pFN21AB6554, Homo sapiens CSNK2A1 gene for casein kinase 2, alpha 1 polypeptide, without stop codon, in Flexi system. CU680000 - Synthetic construct Homo sapiens gateway clone IMAGE:100023360 5' read CSNK2A1 mRNA. DQ595336 - Homo sapiens piRNA piR-61448, complete sequence. JD528960 - Sequence 509984 from Patent EP1572962. JD564068 - Sequence 545092 from Patent EP1572962. JD300545 - Sequence 281569 from Patent EP1572962. JD492206 - Sequence 473230 from Patent EP1572962. DQ587598 - Homo sapiens piRNA piR-54710, complete sequence. JD110918 - Sequence 91942 from Patent EP1572962. JD094883 - Sequence 75907 from Patent EP1572962. JD080727 - Sequence 61751 from Patent EP1572962. JD087961 - Sequence 68985 from Patent EP1572962. JD495834 - Sequence 476858 from Patent EP1572962.
| |
|
|
Biochemical and Signaling Pathways
|
|
Other Names for This Gene
|
|
Alternate Gene Symbols: B4DYS6, CK2A1, CSK21_HUMAN, D3DVV8, ENST00000217244.1, ENST00000217244.2, ENST00000217244.3, ENST00000217244.4, ENST00000217244.5, ENST00000217244.6, ENST00000217244.7, ENST00000217244.8, NM_177559, P19138, P20426, P68400, Q14013, Q5U065, uc317ctg.1, uc317ctg.2 UCSC ID: ENST00000217244.9_8 RefSeq Accession: NM_177559.3
Protein: P68400
(aka CSK21_HUMAN or KC21_HUMAN)
| |
|
|
GeneReviews for This Gene
|
|
GeneReviews article(s) related to gene CSNK2A1: okur-chung (Okur-Chung Neurodevelopmental Syndrome)
| |
|
|
Gene Model Information
|
|
Click here
for a detailed description of the fields of the table above.
| |
|
|
Methods, Credits, and Use Restrictions
|
|
Click here
for details on how this gene model was made and data restrictions if any.
| |
|
|
|